• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC EUROPE SARL COBALT¿ XT HF QUAD CRT-D MRI SURESCAN¿; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC EUROPE SARL COBALT¿ XT HF QUAD CRT-D MRI SURESCAN¿; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number DTPA2QQ
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Dyspnea (1816); Hemorrhage/Bleeding (1888); Intracranial Hemorrhage (1891); Muscle Weakness (1967); Pain (1994); Pleural Effusion (2010); Pulmonary Edema (2020); Tachycardia (2095); Stenosis (2263); Obstruction/Occlusion (2422); Respiratory Failure (2484); Syncope/Fainting (4411); Hemorrhagic Stroke (4417); Heart Failure/Congestive Heart Failure (4446)
Event Date 09/03/2022
Event Type  Death  
Event Description
It was reported that two days after a new cardiac resynchronization therapy defibrillator (crt-d) was implanted for a generator change procedure, the patient was hospitalized for a thromboembolic cerebral vascular accident (cva) at the middle cerebral artery and a thrombectomy was performed.It was noted that prior to the generator change procedure, the patient's anticoagulant medication had been held and were resumed the night before the procedure.About 6 days later the patient was transferred to an acute rehabilitation facility but returned by emergency medical services to the emergency room (er) later that day for worsening right-sided weakness and respiratory distress.The patient also experienced pain in their right foot and syncope.It was also noted that the crt-d had delivered appropriate therapy for monomorphic ventricular tachycardia (vt).It was then noted that an antiarrhythmic meditation had not been given to the patient because it had been incorrectly documented as "declined" in the patient's chart.Antiarrhythmic meditation was provided to the patient.A computerized tomography (ct) scan was performed and revealed an iliac occlusion and a renal artery occlusion.The ct scan also revealed extensive bilateral pulmonary edema, severe cardiomegaly, bilateral pleural effusions, a left frontal intraparenchymal hemorrhage with surrounding edema, and a small amount of subarachnoid hemorrhage within left frontal sulci.Emergent intervention of the right lower leg was performed with vascular thrombectomy.An ultrasound revealed complete occlusions in several femoral arteries consistent with severe stenosis.The patient also developed a pulmonary embolism with congestive heart failure and the patient experienced acute hypoxemic respiratory failure that required bilevel positive airway pressure (bipap).Approximately four days after the return to the emergency room, the patient's family chose to proceed with comfort care and the crt-d defibrillation therapy was programmed off.The patient passed away the next day.The cause of death was listed as renal artery occlusion.The patient is a participant in a clinical study.
 
Manufacturer Narrative
Concomitant medical products: 429888 lead, implanted: (b)(6) 2017; medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBALT¿ XT HF QUAD CRT-D MRI SURESCAN¿
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
SZ  1131
Manufacturer (Section G)
MEDTRONIC EUROPE SARL
route du molliau 31
case postale
tolochenaz vaud 1131
SZ   1131
Manufacturer Contact
paula bixby
8200 coral sea st ne
mounds view, MN 55112
7635055378
MDR Report Key15941278
MDR Text Key305076081
Report Number9614453-2022-03814
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00763000178093
UDI-Public00763000178093
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/08/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/14/2023
Device Model NumberDTPA2QQ
Device Catalogue NumberDTPA2QQ
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/23/2022
Date Device Manufactured06/23/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6947M55 LEAD, 5076-45 LEAD,
Patient Outcome(s) Death;
Patient Age62 YR
Patient SexFemale
Patient RaceWhite
-
-